Iht Wealth Management, LLC Atreca, Inc. Transaction History

Iht Wealth Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2022 May 16, 2022	BUY	$1.61 - $5.2 $20,946 - $67,652	13,010 New	13,010 $41,000
Q4 2021 Feb 14, 2022	SELL	$2.87 - $6.29 $32,172 - $70,510	-11,210 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$4.91 - $9.07 $982 - $1,814	-200 Reduced 1.75%	11,210 $70,000
Q2 2021 Aug 16, 2021	BUY	$7.82 - $13.8 $89,226 - $157,458	11,410 New	11,410 $97,000

30.6K

Ticker BCEL
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 31,876,000
Description
Atreca, Inc., a clinical-stage biopharmaceutical company, discovers and develops antibody-based immunotherapeutics to treat a range of solid tumor types. Its lead product candidate is ATRC-101, a monoclonal antibody with a novel mechanism of action and target derived from an antibody identified using its discovery platform. The company's ATRC-10...

Get notified when there are updates to the investment portfolio of Iht Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Iht Wealth Management, LLC with notifications on news.